Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer

The tumor‐stroma ratio (TSR) has proven to be a strong prognostic factor in breast cancer, demonstrating better survival for patients with stroma‐low tumors. Since the role of the TSR as a predictive marker for neoadjuvant chemotherapy outcome is yet unknown, this association was evaluated for HER2‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagenaars, Sophie C., de Groot, Stefanie, Cohen, Danielle, Dekker, Tim J. A., Charehbili, Ayoub, Meershoek‐Klein Kranenbarg, Elma, Duijm‐de Carpentier, Marjolijn, Pijl, Hanno, Putter, Hein, Tollenaar, Rob A. E. M., Kroep, Judith R., Mesker, Wilma E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Tumor Immunology and Microenvironment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362217/
https://www.ncbi.nlm.nih.gov/pubmed/34043821
http://dx.doi.org/10.1002/ijc.33700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362217/
https://www.ncbi.nlm.nih.gov/pubmed/34043821
http://dx.doi.org/10.1002/ijc.33700

Ejemplares similares